PFE ABR 200 Pill - pink oval, 18mm
Generic Name: abrocitinib
Pill with imprint PFE ABR 200 is Pink, Oval and has been identified as Cibinqo 200 mg. It is supplied by Pfizer Inc.
Cibinqo is used in the treatment of Atopic Dermatitis and belongs to the drug class selective immunosuppressants. Cibinqo 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PFE ABR 200
Cibinqo
- Generic Name
- abrocitinib
- Imprint
- PFE ABR 200
- Strength
- 200 mg
- Color
- Pink
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0435
See also:
Opzelura
Opzelura is used to treat atopic dermatitis (eczema) and nonsegmental vitiligo. It is a topical ...
Eucrisa
Eucrisa (crisaborole) is used to treat mild to moderate eczema (atopic dermatitis) Includes Eucrisa ...
Adbry
Adbry is used to treat moderate-to-severe atopic dermatitis (eczema) in adults and children aged 12 ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Temovate
Temovate is used for atopic dermatitis, dermatitis, dermatological disorders, eczema, lichen ...
Lidex
Lidex is used for atopic dermatitis, dermatitis, eczema, psoriasis
Clobex
Clobex is used for atopic dermatitis, dermatitis, dermatological disorders, eczema, lichen planus ...
Lidex-E
Lidex-E is used for atopic dermatitis, dermatitis, eczema, psoriasis
Clobevate
Clobevate is used for atopic dermatitis, dermatitis, dermatological disorders, eczema, lichen ...
More about Cibinqo (abrocitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.